Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results
02. September 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Reports Preliminary Fiscal 2021 Fourth Quarter and Full Year Revenue Results
29. Juli 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., July 29, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Receives Health Canada Approval for neXus
04. März 2021 09:25 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Participate in Upcoming March Investor Conferences
01. März 2021 08:07 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., March 01, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix to Participate at Upcoming Investor Conferences
11. Februar 2021 10:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix Announces the Second Largest U.S. Commercial Payer Has Provided Coverage for TheraSkin® to Treat All Lower Extremity Dermal Wounds Adding 32 Million New Covered Lives
18. Dezember 2020 10:14 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Dec. 18, 2020 (GLOBE NEWSWIRE) -- 2020) – Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that...
Misonix to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
23. November 2020 10:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix to Participate at Upcoming Craig-Hallum and Canaccord Genuity Investor Conferences
12. November 2020 10:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix to Present at the 40th Annual Canaccord Genuity Growth Conference
30. Juli 2020 08:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., July 30, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix Reports Preliminary Fiscal 2020 Fourth Quarter Revenue of Approximately $13.5 Million
10. Juli 2020 07:00 ET
|
MISONIX, Inc.
Full Year Revenue of Approximately $62.3 Million Company Focus on Shareholder Value Creation, Cash Preservation, Expense Reduction, Workforce Efficiency and Operational Synergies FARMINGDALE,...